论文部分内容阅读
Ｓａｎｏｆｉ－Ｓｙｎｔｈｅｌａｂｏ公司和Ｂｒｉｓｔｏｌ－Ｍｙｅｒｓ Ｓｑｕｉｂｂ公司的抗凝药氯吡格雷（ｃｌｏｐｉｄｏｇｒｅｌ，Ｐｌａｖｉｘ／Ｉｓｃｏｖｅｒ）能使不稳定型心绞痛病人或非Ｑ波心肌梗死病人发生心肌梗死、中风以及死亡事件的危险率明显降低（降低２０％
Sanofi-Synthelabo and Bristol-Myers Squibb’s anticoagulant clopidogrel (Plavix / Iscover) significantly increased the risk of MI, stroke, and death among patients with unstable angina or non-Q-wave myocardial infarction Reduce (decrease by 20%